# High-cutoff Hemodialyzer to Reduce Chronic Inflammation in Hemodialysis Patients

> **NCT00974779** · PHASE2,PHASE3 · COMPLETED · sponsor: **Martin-Luther-Universität Halle-Wittenberg** · enrollment: 19 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** HCO1100 dialyzer
- **DEVICE:** regular dialysis polyamide

## Key facts

- **NCT ID:** NCT00974779
- **Lead sponsor:** Martin-Luther-Universität Halle-Wittenberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-08
- **Final completion:** 2011-12
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-01-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00974779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00974779, "High-cutoff Hemodialyzer to Reduce Chronic Inflammation in Hemodialysis Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00974779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
